[18F]FDG PET/CT for Prognosis and Toxicity Prediction of Diffuse Large B Cell Lymphoma Patients With Chimeric Antigen Receptor T Cell Therapy

The authors evaluated the value of [18F]fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) combining with clinical indices and laboratory indicators in predicting outcomes and toxicity of anti-CD19 CAR T-cell therapy for diffuse large B-cell lymphoma patients.